To further validate the regulatory role of FTO in ovarian cancer progression, we established a subcutaneous xenograft tumor model by injecting SKOV3 cells with either FTO knockout or FTO overexpression constructs into nude mice. This evidence concerns the gene FTO and neoplasm.